Cytokinetics Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cytokinetics (CYTK) Heart Failure Drug Fails to Win FDA Backing in 8-3 Vote
December 13, 2022 4:16 PM ESTCytokinetics (NASDAQ: CYTK) Heart Failure Drug Fails to Win FDA Backing in 8-3 Vote



